JosephLYozviakDOFACP, AAHIVS
Internal Medicine • Allentown, PAHIV/AIDS Medicine
LVHN Comprehensive Health Services and Hepatitis Care Center
Dr. Yozviak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1627 Chew St
Fl 1
Allentown, PA 18102Phone+1 610-969-2800Fax+1 484-884-0699
Summary
- Joseph Yozviak, DO, is an Internal Medicine specialist based in Allentown, PA. His subspecialty is in HIV/AIDS Medicine. Dr. Yozviak earned his degree from the Philadelphia College of Osteopathic Medicine in 2003 and completed his Residency in Internal Medicine between 2003-2006 at Lehigh Valley Health Network. He has extensive experience in dealing with hepatitis B, hepatitis C, HIV/AIDS, anti-retroviral agents, and prep (HIV pre-exposure prophylaxis). Dr. Yozviak is also a distinguished author, with several publications in renowned medical journals such as The New England Journal of Medicine and JAMA.
Education & Training
Lehigh Valley Health NetworkResidency, Internal Medicine, 2003 - 2006
Philadelphia College of Osteopathic MedicineClass of 2003
Certifications & Licensure
PA State License 2003 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 326 citationsDaclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1David L. Wyles, Peter Ruane, Mark S. Sulkowski, Douglas T. Dieterich, Anne F Luetkemeyer
The New England Journal of Medicine. 2015-08-19 - 102 citationsDaclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated CirrhosisAndrew J. Muir, Fred Poordad, Jacob Lalezari, Gregory T. Everson, Gregory J. Dore
JAMA. 2015-05-05 - 6 citationsResuppression of Virus Load after Interruption in Treatment with Nevirapine and 2 Nucleoside Reverse-Transcriptase InhibitorsJ. L. Yozviak, R. E. Doerfler, W. C. Woodward
Clinical Infectious Diseases. 2002-02-15
Press Mentions
Lehigh Valley Health Network to Participate in Pfizer Study to Determine Need for COVID Booster ShotJuly 20th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
